Drug profile · INN
dutasteride
APO-DUTASTERIDE
dutasteride (APO-DUTASTERIDE) is a steroid 5-alpha-reductase inhibitor. Associated with GlaxoSmithKline. Route of administration: oral. Current US regulatory status: approved.
Drug details — dutasteride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 3
- Data quality
- 0.89
Quick answer
dutasteride (APO-DUTASTERIDE) is a steroid 5-alpha-reductase inhibitor. Associated with GlaxoSmithKline. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Steroid 5-alpha-reductase inhibitor
Primary target: Steroid 5-alpha-reductase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is dutasteride?
dutasteride (APO-DUTASTERIDE) is a steroid 5-alpha-reductase inhibitor. Associated with GlaxoSmithKline. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dutasteride?
APO-DUTASTERIDE is a marketed brand name for dutasteride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dutasteride?
dutasteride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.